Toronto, Canada (PRWEB) January 07, 2013
On Friday January 18, 2013 from 2 to 3pm at the Still Mind Zendo* center in New York City, RxISK.org will be hosting a free public discussion about links between school shootings, other violent acts, and common prescription medications with Dr. David Healy, MD, a world-renowned psychiatrist and psychopharmacologist from the United Kingdom.
Dr. Healy has acted as an expert witness for the plaintiff in several high profile trials in the United States and elsewhere where violent acts and prescription drugs were successfully linked. He has authored more than 150 peer-reviewed articles, 200 other pieces, and 20 books, including Pharmageddon from University of California Press, The Antidepressant Era and The Creation of Psychopharmacology from Harvard University Press, The Psychopharmacologists Volumes 1-3 and Let Them Eat Prozac from New York University Press, and Mania from Johns Hopkins University Press.
“With over 90% of school shooters on antidepressants, we need to have a serious discussion about the role that prescription drugs might have played in the recent Connecticut massacre and other mass killings”, says Dr. Healy, CEO of RxISK.org.
After a brief presentation by Dr. Healy, journalists and the public will have an opportunity to ask questions.
Even though the event is free, people need to register at NYC-RxISK.eventbrite.com as space is limited. Still Mind Zendo center is located on the 6th floor at 37 West 17th Street, New York City.
About Data Based Medicine Americas Ltd.
RxISk.org is owned and operated by Data Based Medicine Americas Ltd. (DBM), based in Toronto, Canada. DBM's founders have international reputations in early drug-side-effect detection and risk mitigation, pharmacovigilance, and patient-centered care. Although drug side effects are known to be a leading cause of death and disability, less than 5% of serious drug side effects are reported. DBM’s mission is to capture this missing data directly from patients through RxISK.org’s free drug side effect reporting tool and use this data to help make medicines safer for all of us.
Dr. Healy will be in North America from January 14th to the 21st. If you are interested in interviewing Dr. Healy while he is here please contact:
+1 (647) 799-3792
Dr. David Healy